Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemonaïve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program

@article{Santoro2008PemetrexedPC,
  title={Pemetrexed Plus Cisplatin or Pemetrexed Plus Carboplatin for Chemona{\"i}ve Patients with Malignant Pleural Mesothelioma: Results of the International Expanded Access Program},
  author={A. Santoro and M. O'Brien and R. Stahel and K. Nackaerts and P. Baas and M. Karthaus and W. Eberhardt and L. Paz-Ares and S. Sundstr{\o}m and Y. Liu and V. Ripoche and J. Blatter and C. Visseren-Grul and C. Manegold},
  journal={Journal of Thoracic Oncology},
  year={2008},
  volume={3},
  pages={756-763}
}
  • A. Santoro, M. O'Brien, +11 authors C. Manegold
  • Published 2008
  • Medicine
  • Journal of Thoracic Oncology
  • Introduction: Previously published results from a randomized phase III study of pemetrexed plus cisplatin in patients with malignant pleural mesothelioma (MPM) demonstrated a significant survival benefit and higher response rate compared with cisplatin. Although pemetrexed was under review by regulatory agencies, an International Expanded Access Program (EAP) provided more than 3000 mesothelioma patients with access to single-agent pemetrexed or pemetrexed in combination with cisplatin or… CONTINUE READING
    158 Citations

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    This is a phase II, monocentric study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with MPM expressing PDGFR-beta and/or C-kit by… Expand
    ConditionsMesothelioma, Malignant
    InterventionDrug
    Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
    • 70
    • Highly Influenced
    • PDF
    Pemetrexed in the treatment of malignant mesothelioma: results from an expanded access program in Germany.
    • 19
    • PDF

    References

    SHOWING 1-10 OF 35 REFERENCES
    Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.
    • 2,358
    Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.
    • G. Ceresoli, P. Zucali, +10 authors A. Santoro
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2006
    • 219
    Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma.
    • A. Hughes, P. Calvert, +8 authors H. Calvert
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2002
    • 149
    Randomized phase II trial of cisplatin with mitomycin or doxorubicin for malignant mesothelioma by the Cancer and Leukemia Group B.
    • A. Chahinian, K. Antman, +7 authors L. Leone
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 1993
    • 151
    Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma.
    • 37